-
公开(公告)号：US20160199389A1
公开(公告)日：2016-07-14
申请号：US15000849
申请日：2016-01-19
申请人： REGENERA PHARMA LTD.
发明人： Zadik Hazan , Andre C. B. Lucassen
IPC分类号： A61K31/569 , A61K31/19
CPC分类号： A61K31/569 , A61K31/19 , A61K31/57 , A61K36/22 , A61K2236/39 , C12N2501/999 , C12N2506/00
摘要： The invention relates to compositions and formulations comprising isolated acidic fraction of mastic gum and uses thereof for treating impaired neurological functions as well as wound and tissue repair.
-
公开(公告)号：US11173164B2
公开(公告)日：2021-11-16
申请号：US16750472
申请日：2020-01-23
申请人： REGENERA PHARMA LTD.
IPC分类号： A61K31/56 , A61K45/06 , A61K31/569 , A61K31/575 , A61K31/745 , A61K36/22 , A61K31/122
摘要： The invention relates to compositions and formulations comprising at least one triterpenoic acid and at least one neutral triterpenoid and uses thereof for treating for use in treating a condition selected from Alzheimer's disease (AD), Parkinson's Diseases (PD) and vascular dementia (VD).
-
公开(公告)号：US11083736B2
公开(公告)日：2021-08-10
申请号：US16451621
申请日：2019-06-25
申请人： REGENERA PHARMA LTD.
IPC分类号： A61K31/575 , A61K45/06 , A61K36/22 , A61K31/569 , A61K31/745 , A61P9/10 , A61K31/047 , A61K31/122 , A61K31/56
摘要： The invention relates to compositions and formulations comprising at least one triterpenoic acid and at least one neutral triterpenoid and uses thereof for treating stroke or trauma and side effects related thereto.
-
公开(公告)号：US11000562B2
公开(公告)日：2021-05-11
申请号：US15556504
申请日：2016-03-07
申请人： REGENERA PHARMA LTD.
摘要： The invention relates to therapeutic uses of isolated fractions of mastic gum for treating optic neuropathy. More particularly, the invention relates to methods of treating optic neuropathy conditions using compositions comprising isolated fractions of mastic gum.
-
公开(公告)号：US11207333B2
公开(公告)日：2021-12-28
申请号：US16330486
申请日：2017-09-07
申请人： REGENERA PHARMA LTD.
IPC分类号： A61K31/575 , A61K31/047 , A61K31/19 , A61K36/22 , A61K31/56 , A61P25/00 , A61K31/045 , A61P27/06 , A61K47/44 , A61K9/00
摘要： The invention relates to compositions and formulations comprising at least one triterpenoic acid and at least one neutral triterpenoid and uses thereof for treating optic neuropathy conditions.
-
公开(公告)号：US10806763B2
公开(公告)日：2020-10-20
申请号：US16391881
申请日：2019-04-23
申请人： REGENERA PHARMA LTD.
发明人： Zadik Hazan , Shimon Amselem
摘要： Compositions and formulations comprising polymeric myrcene. More particularly, the invention relates to compositions comprising an isolated fraction of polymeric myrcene in a hydrophobic carrier and formulations which maintain the biological activity of the active polymer.
-
公开(公告)号：US10307449B2
公开(公告)日：2019-06-04
申请号：US15486964
申请日：2017-04-13
申请人： REGENERA PHARMA LTD.
发明人： Zadik Hazan , Shimon Amselem
摘要： Compositions and formulations comprising polymeric myrcene. More particularly, the invention relates to compositions comprising an isolated fraction of polymeric myrcene in a hydrophobic carrier and formulations which maintain the biological activity of the active polymer.
-
公开(公告)号：US10588911B2
公开(公告)日：2020-03-17
申请号：US16359068
申请日：2019-03-20
申请人： REGENERA PHARMA LTD.
IPC分类号： A61K31/56 , A61K45/06 , A61K31/569 , A61K31/575 , A61K31/745 , A61K36/22 , A61K31/122
摘要： The invention relates to compositions and formulations comprising at least one triterpenoic acid and at least one neutral triterpenoid and uses thereof for treating for use in treating a condition selected from Alzheimer's disease (AD), Parkinson's Diseases (PD) and vascular dementia (VD).
-
公开(公告)号：US10561670B2
公开(公告)日：2020-02-18
申请号：US16190780
申请日：2018-11-14
申请人： REGENERA PHARMA LTD.
发明人： Zadik Hazan , Andre C. B. Lucassen
IPC分类号： A61K36/22 , B01D11/02 , A61K31/569 , A61K31/57 , A61K31/19
摘要： The invention relates to compositions and formulations comprising isolated acidic fraction of mastic gum and uses thereof for treating impaired neurological functions as well as wound and tissue repair.
-
公开(公告)号：US10285996B2
公开(公告)日：2019-05-14
申请号：US15761759
申请日：2016-09-22
申请人： REGENERA PHARMA LTD.
IPC分类号： A61K31/56 , A61K36/22 , A61K45/06 , A61K31/122 , A61K31/569 , A61K31/575 , A61K31/745
摘要： The invention relates to compositions and formulations comprising at least one triterpenoic acid and at least one neutral triterpenoid and uses thereof for treating for use in treating a condition selected from Alzheimer's disease (AD), Parkinson's Diseases (PD) and vascular dementia (VD).
-
-
-
-
-
-
-
-
-
搜索结果
17 条记录 (耗时 0.023 秒)
